🤖 AI Summary
Micro-ultrasound (micro-US) imaging for prostate cancer (PCa) detection faces challenges including strong tissue heterogeneity, severe class imbalance among benign tissues, and scarcity of high-quality annotated data. To address these, we propose the first trustworthy AI framework specifically designed for micro-US. Our method integrates uncertainty quantification—implemented via Monte Carlo DropPath—with multi-scale feature calibration, an attention-guided lesion localization module, and a clinical-prior-driven post-processing strategy. Built upon an enhanced U-Net architecture, it significantly improves robustness and interpretability in detecting small lesions and low-contrast regions. Experiments on a multicenter dataset achieve 92.3% sensitivity and 89.7% specificity, with a 37% reduction in false-positive rate. In blinded clinical evaluation by radiologists, our framework demonstrates high inter-rater agreement (Cohen’s κ = 0.86), confirming strong clinical consistency.